Higher REM Sleep Linked to Lower Risk of 83 Diseases in UK Biobank Study

In an analysis of 44,000 adults tracked by the UK Biobank, researchers found that individuals who spent a larger fraction of their night in rapid eye movement (REM) sleep showed a lower risk of developing 83 distinct diseases over the following decade. The findings, published in September 2026, shift the clinical focus from total sleep duration to the specific architecture of how those hours are spent.[1][2]

Public health guidelines typically recommend seven to eight hours of total rest per night for adults. However, the new data indicates that the composition of those hours—specifically the proportion of REM and deep sleep—plays a critical role in long-term disease prevention.[3]

The research team utilized wrist-worn accelerometers to monitor the sleep patterns of participants, whose average age was 62. By cross-referencing this continuous tracking data with electronic medical records, they identified protective associations against a wide spectrum of conditions, including type 2 diabetes, heart failure, and depression.[2][4]

"How you sleep, not just how much, influences what diseases you get in later life," noted the report from The Independent, summarizing the core shift in perspective. The study demonstrates that simply spending nine hours in bed offers limited protection if the brain fails to cycle through the necessary restorative phases.[3]

REM sleep, which typically accounts for 20 to 25 percent of a healthy adult's night, is characterized by heightened brain activity and dreaming. Deep sleep, or slow-wave sleep, is crucial for physical restoration and memory consolidation. The UK Biobank analysis found that deficits in either stage correlated with higher disease incidence.[1][2]

For the general public, these findings suggest that interventions aimed at improving sleep quality might yield broader protective benefits than simply extending time in bed. Practical steps include maintaining a cool bedroom environment, limiting alcohol consumption before sleep, and seeking treatment for conditions like obstructive sleep apnea, which repeatedly interrupts REM cycles.[2][5]

Independent experts reviewing the data highlighted the robust statistical power provided by the 44,000-person cohort. Tracking this volume of individuals allowed the research team to adjust for confounding variables such as body mass index, physical activity levels, and socioeconomic status, isolating the specific impact of sleep stages.[5]

The observational nature of the UK Biobank data means researchers cannot definitively prove that a lack of REM sleep directly causes these 83 conditions. Experts caution that reverse causation remains a possibility: early, undetected stages of certain diseases might disrupt sleep architecture years before a formal clinical diagnosis occurs.[5]

The next verifiable checkpoint for sleep medicine involves developing accessible, clinical-grade tools to measure sleep architecture at home. If primary care physicians can reliably track REM and deep sleep outside of specialized laboratories, they may be able to identify at-risk patients long before metabolic or cardiovascular symptoms emerge.[2][3]